-
Mashup Score: 1
Germline pathogenic variants (GPVs) in the cancer predisposition genes BRCA1 , BRCA2 , MLH1 , MSH2 , MSH6 , BRIP1 , PALB2 , RAD51D and RAD51C are identified in approximately 15% of patients with ovarian cancer (OC). While there are clear guidelines around clinical management of cancer risk in patients with GPV in BRCA1 , BRCA2 , MLH1 , MSH2 and MSH6 , there are few guidelines on how to manage the…
Source: Journal of Medical GeneticsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
UK guidelines for clinical management of cancer risk in patients with pathogenic variants in #RAD51C #RAD51D #BRIP1 #PALB2 #OpenAccess - https://t.co/Yq69UpxPom @Helen_Hanson1 @Anju__Kulkarni @antonis02 @ProfManchanda @clare__turnbull @ER_Woodward @tischkowitz @UKCGG #Cancer https://t.co/EBiGX3pao7